Patents by Inventor KATHARINA WARTHA

KATHARINA WARTHA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating colon cancer or inhibiting cell proliferation by administering a combination of antibodies against human CSF-1R and antibodies against human PD-L1
    Patent number: 11512133
    Abstract: The present invention relates to the combination therapy of specific antibodies which bind human CSF-1R with specific antibodies which bind human PD-L1.
    Type: Grant
    Filed: February 6, 2020
    Date of Patent: November 29, 2022
    Assignee: HOFFMANN-LA ROCHE INC.
    Inventors: Frank Herting, Sabine Hoves, Carola Ries, Katharina Wartha
  • COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND ANTIBODIES AGAINST HUMAN PD-L1
    Publication number: 20200392234
    Abstract: The present invention relates to the combination therapy of specific antibodies which bind human CSF-1R with specific antibodies which bind human PD-L1.
    Type: Application
    Filed: February 6, 2020
    Publication date: December 17, 2020
    Applicant: HOFFMANN-LA ROCHE INC.
    Inventors: Frank HERTING, Sabine HOVES, Carola RIES, Katharina WARTHA
  • COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND USES THEREOF
    Publication number: 20190185572
    Abstract: The present invention relates to the combination therapy of antibodies binding to human CSF-1R, characterized in binding to the (dimerization) domains D4 to D5 (SEQ ID No: 85) of the extracellular domain of human CSF-1R in combination with a chemotherapeutic agent, radiation, and/or cancer immunotherapy.
    Type: Application
    Filed: December 4, 2018
    Publication date: June 20, 2019
    Applicant: HOFFMANN-LA ROCHE INC.
    Inventors: Michael CANNARILE, Carola RIES, Dominik RUETTINGER, Katharina WARTHA
  • COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND ANTIBODIES AGAINST HUMAN PD-L1
    Publication number: 20180346581
    Abstract: The present invention relates to the combination therapy of specific antibodies which human CSF-1R with specific antibodies which bind human PD-L1.
    Type: Application
    Filed: April 19, 2018
    Publication date: December 6, 2018
    Applicant: HOFFMANN-LA ROCHE INC.
    Inventors: Frank HERTING, Sabine HOVES, Carola RIES, Katharina WARTHA
  • Bispecific antibodies
    Patent number: 10106600
    Abstract: The present invention relates to bispecific antibodies, methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.
    Type: Grant
    Filed: March 24, 2011
    Date of Patent: October 23, 2018
    Assignee: Roche Glycart AG
    Inventors: Ulrich Brinkmann, Rebecca Croasdale, Harald Duerr, Christian Klein, Erhard Kopetzki, Wilma Lau, Joerg Thomas Regula, Juergen Michael Schanzer, Pablo Umana, Katharina Wartha
  • COMBINATION THERAPY OF BISPECIFIC ANTIBODIES SPECIFIC FOR FAP AND DR5 AND CHEMOTHERAPEUTIC AGENTS
    Publication number: 20180064808
    Abstract: The present invention relates to bispecific antibodies comprising at least one antigen binding site specific for DR5 and at least one antigen binding site specific for FAP, antibodies specific for DR5, and in particular to combination therapies employing such bispecific antibodies and a chemotherapeutic agent, and their use of these combination therapies for the treatment of cancer.
    Type: Application
    Filed: April 7, 2017
    Publication date: March 8, 2018
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Thomas Friess, Oliver Krieter, Meher Majety, Katharina Wartha
  • COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND USES THEREOF
    Publication number: 20170247459
    Abstract: The present invention relates to the combination therapy of antibodies binding to human CSF-1R, characterized in binding to the (dimerization) domains D4 to D5 (SEQ ID No: 85) of the extracellular domain of human CSF-1R in combination with a chemotherapeutic agent, radiation, and/or cancer immunotherapy.
    Type: Application
    Filed: October 7, 2016
    Publication date: August 31, 2017
    Applicant: HOFFMANN-LA ROCHE INC.
    Inventors: Michael CANNARILE, Carola RIES, Dominik RUETTINGER, Katharina WARTHA
  • Bispecific anti-EGFR/anti IGF-1R antibodies
    Patent number: 9650442
    Abstract: The present invention relates to bispecific anti-EGFR/anti IGF-1R antibodies, methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.
    Type: Grant
    Filed: March 20, 2014
    Date of Patent: May 16, 2017
    Assignee: Roche Glycart AG
    Inventors: Ralf Hosse, Christian Klein, Ekkehard Moessner, Juergen Michael Schanzer, Cuiying Shao, Lei Shi, Pablo Umana, Peng Wang, Katharina Wartha
  • COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND ANTIBODIES AGAINST HUMAN PD-L1
    Publication number: 20170051065
    Abstract: The present invention relates to the combination therapy of specific antibodies which bind human CSF-1R with specific antibodies which bind human PD-L1.
    Type: Application
    Filed: July 29, 2016
    Publication date: February 23, 2017
    Applicant: HOFFMANN-LA ROCHE INC.
    Inventors: Frank HERTING, Sabine HOVES, Carola RIES, Katharina WARTHA
  • COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND TLR9 AGONIST
    Publication number: 20160220669
    Abstract: The present invention relates to the combination therapy of antibodies against human CSF-1R with a TLR9 agonist.
    Type: Application
    Filed: October 16, 2015
    Publication date: August 4, 2016
    Applicant: HOFFMANN-LA ROCHE INC.
    Inventors: Sabine HOVES, Carola RIES, Dominik RUETTINGER, Katharina WARTHA
  • Method of treating cancer by administering CSF-1R antibodies and a TLR9 agonist
    Patent number: 9192667
    Abstract: The present invention relates to the combination therapy of antibodies against human CSF-1R with a TLR9 agonist.
    Type: Grant
    Filed: April 21, 2014
    Date of Patent: November 24, 2015
    Assignee: HOFFMANN-LA ROCHE INC.
    Inventors: Sabine Hoves, Carola Ries, Dominik Ruettinger, Katharina Wartha
  • Combination therapy of antibodies against human CSF-1R and antibodies agains human PD-L1
    Publication number: 20150073129
    Abstract: The present invention relates to the combination therapy of specific antibodies which bind human CSF-1R with specific antibodies which bind human PD-L1.
    Type: Application
    Filed: September 12, 2014
    Publication date: March 12, 2015
    Applicant: HOFFMANN-LA ROCHE INC.
    Inventors: Frank Herting, Sabine Hoves, Carola Ries, Katharina Wartha
  • COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND TLR9 AGONIST
    Publication number: 20140314771
    Abstract: The present invention relates to the combination therapy of antibodies against human CSF-1R with a TLR9 agonist.
    Type: Application
    Filed: April 21, 2014
    Publication date: October 23, 2014
    Applicant: HOFFMANN-LA ROCHE INC.
    Inventors: Sabine Hoves, Carola Ries, Dominik Ruettinger, Katharina Wartha
  • BISPECIFIC ANTI-EGFR/ANTI IGF-1R ANTIBODIES
    Publication number: 20140193415
    Abstract: The present invention relates to bispecific anti-EGFR/anti IGF-1R antibodies, methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.
    Type: Application
    Filed: March 20, 2014
    Publication date: July 10, 2014
    Applicant: ROCHE GLYCART AG
    Inventors: Ralf Hosse, Christian Klein, Ekkehard Moessner, Juergen Michael Schanzer, Cuiying Shao, Lei Shi, Pablo Umana, Peng Wang, Katharina Wartha
  • BISPECIFIC ANTIBODIES
    Publication number: 20110293613
    Abstract: The present invention relates to bispecific antibodies, methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.
    Type: Application
    Filed: March 24, 2011
    Publication date: December 1, 2011
    Inventors: ULRICH BRINKMANN, REBECCA CROASDALE, HARALD DUERR, CHRISTIAN KLEIN, ERHARD KOPETZKI, WILMA LAU, JOERG THOMAS REGULA, JUERGEN MICHAEL SCHANZER, PABLO UMAÑA, KATHARINA WARTHA